Two-pronged Cell Therapy: Engineering NK cells to target CD22 and redirect bystander T cells to CD19 for the adoptive imrnunotherapy of B-cell malignancies

被引：0
|
作者：
Szoor, Arpad
Velasquez, Mireya Paulina
Bonifant, Challice Lee
Vaidya, Abishek
Brunetti, Lorenzo
Gundry, Michael
Parihar, Robin
Goodell, Margaret
Gottschalk, Stephen
机构：
来源：
JOURNAL OF IMMUNOLOGY | 2017年 / 198卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
198.6
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Loop CD20/CD19 CAR-T cells eradicate B-cell malignancies efficiently
    Zhaoqi Chen
    Yan Liu
    Nianci Chen
    Haiyan Xing
    Zheng Tian
    Kejing Tang
    Qing Rao
    Yingxi Xu
    Ying Wang
    Min Wang
    Jianxiang Wang
    Science China(Life Sciences), 2023, 66 (04) : 754 - 770
  • [22] Loop CD20/CD19 CAR-T cells eradicate B-cell malignancies efficiently
    Zhaoqi Chen
    Yan Liu
    Nianci Chen
    Haiyan Xing
    Zheng Tian
    Kejing Tang
    Qing Rao
    Yingxi Xu
    Ying Wang
    Min Wang
    Jianxiang Wang
    Science China(Life Sciences) , 2023, (04) : 754 - 770
  • [23] Loop CD20/CD19 CAR-T cells eradicate B-cell malignancies efficiently
    Zhaoqi Chen
    Yan Liu
    Nianci Chen
    Haiyan Xing
    Zheng Tian
    Kejing Tang
    Qing Rao
    Yingxi Xu
    Ying Wang
    Min Wang
    Jianxiang Wang
    Science China Life Sciences, 2023, 66 : 754 - 770
  • [24] Loop CD20/CD19 CAR-T cells eradicate B-cell malignancies efficiently
    Chen, Zhaoqi
    Liu, Yan
    Chen, Nianci
    Xing, Haiyan
    Tian, Zheng
    Tang, Kejing
    Rao, Qing
    Xu, Yingxi
    Wang, Ying
    Wang, Min
    Wang, Jianxiang
    SCIENCE CHINA-LIFE SCIENCES, 2023, 66 (04) : 754 - 770
  • [25] Safety and Efficacy of Humanized Versus Murinized CD19 and CD22 CAR T-Cell Cocktail Therapy for Refractory/Relapsed B-Cell Lymphoma
    Huang, Lefu
    Li, Jingjing
    Yang, Junfang
    Zhang, Xian
    Zhang, Min
    He, Jiujiang
    Zhang, Gailing
    Li, Wenqian
    Wang, Hui
    Li, Jianqiang
    Lu, Peihua
    CELLS, 2022, 11 (24)
  • [26] CD19 CAR-T Cells With Membrane-Bound IL-15 for B-Cell Acute Lymphoblastic Leukemia After Failure of CD19 and CD22 CAR-T Cells: Case Report
    Sun, Yao
    Su, Yongfeng
    Wang, Yizhi
    Liu, Na
    Li, Yuhang
    Chen, Jianlin
    Qiao, Zhuoqing
    Niu, Jingwen
    Hu, Jiangwei
    Zhang, Bin
    Ning, Hongmei
    Hu, Liangding
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [27] Structural Optimization of Dual-Target CD22/CD19 CAR-T and Its Anti-Tumor Effects on B Cell Malignancies
    Zhang, Yu
    Wang, Ying
    Gu, Runxia
    Shi, Lin
    Wang, Yongzeng
    Feng, Yi
    Lv, Lulu
    Rao, Qing
    Wang, Min
    Wang, Jianxiang
    BLOOD, 2022, 140
  • [28] Combining CD19 Redirection and Alloanergization to Generate Tumor-Specific Human T Cells for Allogeneic Cell Therapy of B-Cell Malignancies
    Davies, Jeff K.
    Singh, Harjeet
    Huls, Helen
    Yuk, Dongin
    Lee, Dean A.
    Kebriaei, Partow
    Champlin, Richard E.
    Nadler, Lee M.
    Guinan, Eva C.
    Cooper, Laurence J. N.
    CANCER RESEARCH, 2010, 70 (10) : 3915 - 3924
  • [29] Efficacy and safety of chimeric antigen receptor T-cell therapy targeting CD19/CD22 in refractory/relapsed transformed aggressive B-cell lymphoma
    Xu, Hao
    Lv, Qiuxia
    Huang, Liang
    Cao, Wenyue
    Wang, Jue
    Meng, Fankai
    Li, Chunrui
    Zheng, Miao
    Chen, Liting
    Mu, Ketao
    Cheng, Jiali
    Zhu, Li
    Zhou, Jianfeng
    Zhang, Yicheng
    Wang, Na
    Cao, Yang
    CYTOTHERAPY, 2023, 25 (02) : 185 - 191
  • [30] Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies
    Ying, Zhitao
    He, Ting
    Wang, Xiaopei
    Zheng, Wen
    Lin, Ningjing
    Tu, Meifeng
    Xie, Yan
    Ping, Lingyan
    Zhang, Chen
    Liu, Weiping
    Deng, Lijuan
    Wu, Meng
    Feng, Feier
    Leng, Xin
    Du, Tingting
    Qi, Feifei
    Hu, Xuelian
    Ding, Yanping
    Lu, Xin-an
    Song, Yuqin
    Zhu, Jun
    BMC CANCER, 2021, 21 (01)
12345